Method of growing device quality InP onto an InP substrate using an
organometallic precursor in a hot wall reactor
    1.
    发明授权
    Method of growing device quality InP onto an InP substrate using an organometallic precursor in a hot wall reactor 失效
    在热壁反应器中使用有机金属前体将器件质量InP增加到InP衬底上的方法

    公开(公告)号:US5256595A

    公开(公告)日:1993-10-26

    申请号:US19508

    申请日:1993-02-19

    IPC分类号: H01L21/205

    摘要: An organometallic precursor as for example trimethyl indium (TMI) is co-injected with HCl into a hot wall reactor to form volatile InCl, and PH.sub.3 is used as the phosphorus source. Layers of InP are grown at approximately 8 .mu.m/hr with excellent morphology and good electrical properties. Hall measurements at 77K show background n-type conductivity with n=7.times.10.sup.15 /cm.sup.3 and .mu..sup.S 34,000 cm.sub.2 /V-s. The method is capable of growing ternary and quaternary heterostructures with thin layers and abrupt junctions.

    摘要翻译: 将有机金属前体,例如三甲基铟(TMI)与HCl共注入到热壁反应器中以形成挥发性InCl,并且使用PH 3作为磷源。 InP层以约8μm/ hr生长,具有优异的形态和良好的电性能。 在77K的霍尔测量显示n = 7×10 15 / cm 3和mu S 34,000cm 2 / V-s的背景n型导电性。 该方法能够生长具有薄层和突变结的三元和四元异质结构。

    Method and apparatus for growing semiconductor heterostructures
    2.
    发明授权
    Method and apparatus for growing semiconductor heterostructures 失效
    用于生长半导体异质结构的方法和装置

    公开(公告)号:US5254210A

    公开(公告)日:1993-10-19

    申请号:US874779

    申请日:1992-04-27

    摘要: A conventional hydride VPE reactor is modified by the addition of a gas switching manifold and the use of three way pneumatic valves in the manifold to alternately direct the flow of reactant gas mixtures into either the reactor or a vent line. With these additions, various predetermined gas mixtures of arsine, phosphine, and hydrogen selected by electronic mass flow controllers (GM1 and GM2) and predetermined gas mixtures of H.sub.2 and HCl (GM3) may be alternately infused into the reactor chamber or vented as desired. When GM3 is injected into the reactor chamber, the content of GaAs of the growing layer increases while the content of In decreases. Given this, when GM3 and GM2 are vented rather than injected into the furnace and GM1 is directed into the furnace, a layer of InGaAsP with a predetermined composition (A) will be deposited. Alternatively, when GM3 and GM2 are co-injected into the reactor and GM1 is be directed to the vent, a layer of InGaAsP of a predetermined composition (B) will be deposited. Therefore, the flow rates of HCl, PH.sub.3 and AsH.sub.3 can be adjusted to produce compositions A and B that correspond to a lattice-matched condition with either InP or GaAs substrate.

    摘要翻译: 传统的氢化物VPE反应器通过添加气体切换歧管和在歧管中使用三通气动阀来交替地将反应气体混合物的流动引导到反应器或排气管线中来进行修改。 通过这些添加,可以将电子质量流量控制器(GM1和GM2)选择的各种预定的胂,膦和氢的气体混合物和H 2和HCl(GM 3)的预定气体混合物交替地输入到反应器室中或根据需要排气。 当GM3被注入到反应器室中时,生长层的GaAs含量增加,而In的含量减少。 考虑到这一点,当GM3和GM2排放而不是注入炉中,GM1被引入炉中时,将沉积具有预定组成(A)的InGaAsP层。 或者,当将GM3和GM2共注入到反应器中并且GM1被引导到排气口时,将沉积预定组成(B)的InGaAsP层。 因此,可以调节HCl,PH3和AsH3的流量,以产生与InP或GaAs衬底的晶格匹配条件相对应的组分A和B.

    Two-chamber blood pump
    3.
    发明授权
    Two-chamber blood pump 有权
    双室血泵

    公开(公告)号:US09234514B2

    公开(公告)日:2016-01-12

    申请号:US12199593

    申请日:2008-08-27

    申请人: Kenneth A. Jones

    发明人: Kenneth A. Jones

    摘要: A fluid pump for medical applications. The pump includes a flexible cassette containing two pump chambers of differing volume, each chamber having a dedicated piston. The first piston pushes fluid from the first chamber to the second, and the second piston pushes fluid from the second chamber and out of the pump. Three valves are coordinated with the action of the pistons to control fluid flow into and out of the pump chambers by applying and releasing pressure to and from specific points of the flexible cassette. A control system controls the operation of the pistons and valves and directs the pistons to be advanced according to a time-varying velocity profile. The first pump chamber passively fills and then rapidly expels the collected fluid into the second chamber at low pressure. The second chamber, once filled, expels the fluid downstream at high pressure, producing a pulsatile pressure profile.

    摘要翻译: 用于医疗应用的流体泵。 该泵包括一个含有两个不同体积的泵室的柔性盒,每个室具有专用的活塞。 第一活塞将流体从第一腔室推动到第二活塞,第二活塞将流体从第二腔室推出泵出。 三个阀门与活塞的作用协调起来,以通过向和从该软管盒的特定点施加和释放压力来控制流入和流出泵室的流体。 控制系统控制活塞和阀的操作,并根据时变速度分布指示要提前的活塞。 第一泵室被动填充,然后在低压下将收集的流体快速排出到第二室中。 一旦装满了第二个室,高压下排出流体,产生脉动压力分布。

    Methods for preparing compositions using a SNORF33 receptor
    4.
    发明授权
    Methods for preparing compositions using a SNORF33 receptor 失效
    使用SNORF33受体制备组合物的方法

    公开(公告)号:US07517658B2

    公开(公告)日:2009-04-14

    申请号:US11227855

    申请日:2005-09-15

    摘要: This invention provides isolated nucleic acids encoding mammalian SNORF33 receptors, purified mammalian SNORF33 receptors, vectors comprising nucleic acid encoding mammalian SNORF33 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF33 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian SNORF33 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF33 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian SNORF33 receptors, methods of isolating mammalian SNORF33 receptors, methods of treating an abnormality that is linked to the activity of the mammalian SNORF33 receptors, as well as methods of determining binding of compounds to mammalian SNORF33 receptors, methods of identifying agonists and antagonists of SNORF33 receptors, and agonists and antagonists so identified.

    摘要翻译: 本发明提供编码哺乳动物SNORF33受体的分离的核酸,纯化的哺乳动物SNORF33受体,包含编码哺乳动物SNORF33受体的核酸的载体,包含此类载体的细胞,针对哺乳动物SNORF33受体的抗体,用于检测编码哺乳动物SNORF33受体的核酸的核酸探针, 与编码哺乳动物SNORF33受体的核酸的独特序列互补的反义寡核苷酸,表达编码正常或突变的哺乳动物SNORF33受体的DNA的转基因非人动物,分离哺乳动物SNORF33受体的方法,治疗与哺乳动物的活性相关的异常的方法 SNORF33受体以及确定化合物与哺乳动物SNORF33受体的结合的方法,识别SNORF33受体的激动剂和拮抗剂的方法,以及所鉴定的激动剂和拮抗剂。

    DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
    5.
    发明授权
    DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof 失效
    编码哺乳动物神经肽FF(NPFF)受体的DNA及其用途

    公开(公告)号:US06709831B1

    公开(公告)日:2004-03-23

    申请号:US09405558

    申请日:1999-09-24

    IPC分类号: G01N33566

    CPC分类号: C07K14/70571 A01K2217/075

    摘要: This invention provides isolated nucleic acids encoding mammalian NPFF receptors, purified mammalian NPFF receptors, vectors comprising nucleic acid encoding mammalian NPFF receptors, cells comprising such vectors, antibodies directed to mammalian NPFF receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian NPFF receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian NPFF receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian NPFF receptors, methods of isolating mammalian NPFF receptors, methods of treating an abnormality that is linked to the activity of the mammalian NPFF receptors, as well as methods of determining binding of compounds to mammalian NPFF receptors, methods of identifying agonists and antagonists of NPFF receptors, and agonists and antagonists so identified.

    摘要翻译: 本发明提供编码哺乳动物NPFF受体的分离的核酸,纯化的哺乳动物NPFF受体,包含编码哺乳动物NPFF受体的核酸的载体,包含该载体的细胞,针对哺乳动物NPFF受体的抗体,用于检测编码哺乳动物NPFF受体的核酸的核酸探针, 与编码哺乳动物NPFF受体的核酸的独特序列互补的反义寡核苷酸,其表达编码正常或突变型哺乳动物NPFF受体的DNA的转基因非人动物,分离哺乳动物NPFF受体的方法,治疗与哺乳动物活性相关的异常的方法 NPFF受体,以及确定化合物与哺乳动物NPFF受体的结合的方法,识别NPFF受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。

    DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof
    6.
    发明授权
    DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof 失效
    编码哺乳动物神经肽FF(NPFF)受体的DNA及其用途

    公开(公告)号:US06262246B1

    公开(公告)日:2001-07-17

    申请号:US09255368

    申请日:1999-02-22

    IPC分类号: C07H2104

    CPC分类号: C07K14/70571 A01K2217/075

    摘要: This invention provides isolated nucleic acids encoding mammalian NPFF receptors, purified mammalian NPFF receptors, vectors comprising nucleic acid encoding mammalian NPFF receptors, cells comprising such vectors, antibodies directed to mammalian NPFF receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian NPFF receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian NPFF receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian NPFF receptors, methods of isolating mammalian NPFF receptors, methods of treating an abnormality that is linked to the activity of the mammalian NPFF receptors, as well as methods of determining binding of compounds to mammalian NPFF receptors, methods of identifying agonists and antagonists of NPFF receptors, and agonists and antagonists so identified.

    摘要翻译: 本发明提供编码哺乳动物NPFF受体的分离的核酸,纯化的哺乳动物NPFF受体,包含编码哺乳动物NPFF受体的核酸的载体,包含该载体的细胞,针对哺乳动物NPFF受体的抗体,用于检测编码哺乳动物NPFF受体的核酸的核酸探针, 与编码哺乳动物NPFF受体的核酸的独特序列互补的反义寡核苷酸,其表达编码正常或突变型哺乳动物NPFF受体的DNA的转基因非人动物,分离哺乳动物NPFF受体的方法,治疗与哺乳动物活性相关的异常的方法 NPFF受体,以及确定化合物与哺乳动物NPFF受体的结合的方法,识别NPFF受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。

    Method of making a selective compositional disordering of a GaAs based
heterostructure by the in-diffusion of Au through a single crystal,
epitaxially grown Ge film
    7.
    发明授权
    Method of making a selective compositional disordering of a GaAs based heterostructure by the in-diffusion of Au through a single crystal, epitaxially grown Ge film 失效
    通过单晶,外延生长的Ge膜通过Au的扩散形成GaAs基异质结构的选择性组成失调的方法

    公开(公告)号:US5346856A

    公开(公告)日:1994-09-13

    申请号:US60073

    申请日:1993-05-10

    摘要: A method for producing a buried heterostructure active devices and a passive waveguide by providing a heterostructure substrate such as a superlattice having at least one planar GaAs layer and at least one AlGaAs layer adjacent to it. A single crystal germanium layer is epitaxially deposited on the superlattice substrate. A layer of gold is deposited on the germanium layer. The gold and germanium layers are imagewise patterned and selected portions etched away. The patterned substrate is encapsulated in a compatible, heat resistant encapsulating material. The encapsulated substrate is then annealed at a temperature of up to about 350.degree. C.

    摘要翻译: 通过提供具有至少一个平面GaAs层和与其邻近的至少一个AlGaAs层的超晶格等异质结构衬底来制造掩埋异质结构有源器件和无源波导的方法。 单晶锗层外延沉积在超晶格基底上。 一层金沉积在锗层上。 金和锗层是成像图案的,并且选择的部分被蚀刻掉。 图案化衬底被封装在相容的耐热封装材料中。 然后将封装的衬底在高达约350℃的温度下退火

    Methods of identifying agonists and antagonists of mammalian NPFF receptor
    10.
    发明授权
    Methods of identifying agonists and antagonists of mammalian NPFF receptor 失效
    识别哺乳动物NPFF受体的激动剂和拮抗剂的方法

    公开(公告)号:US07041461B2

    公开(公告)日:2006-05-09

    申请号:US09866248

    申请日:2001-05-25

    CPC分类号: C07K14/70571 A01K2217/075

    摘要: This invention provides isolated nucleic acids encoding mammalian NPFF receptors, purified mammalian NPFF receptors, vectors comprising nucleic acid encoding mammalian NPFF receptors, cells comprising such vectors, antibodies directed to mammalian NPFF receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian NPFF receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian NPFF receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian NPFF receptors, methods of isolating mammalian NPFF receptors, methods of treating an abnormality that is linked to the activity of the mammalian NPFF receptors, as well as methods of determining binding of compounds to mammalian NPFF receptors, methods of identifying agonists and antagonists of NPFF receptors, and agonists and antagonists so identified.

    摘要翻译: 本发明提供编码哺乳动物NPFF受体的分离的核酸,纯化的哺乳动物NPFF受体,包含编码哺乳动物NPFF受体的核酸的载体,包含该载体的细胞,针对哺乳动物NPFF受体的抗体,用于检测编码哺乳动物NPFF受体的核酸的核酸探针, 与编码哺乳动物NPFF受体的核酸的独特序列互补的反义寡核苷酸,其表达编码正常或突变型哺乳动物NPFF受体的DNA的转基因非人动物,分离哺乳动物NPFF受体的方法,治疗与哺乳动物活性相关的异常的方法 NPFF受体,以及确定化合物与哺乳动物NPFF受体的结合的方法,识别NPFF受体的激动剂和拮抗剂的方法,以及如此鉴定的激动剂和拮抗剂。